mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.7 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |